Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Material Separation from Polyester/Cotton Blended Fabrics Using Hydrothermal Treatment.

Autor: Matsumura M; Tsuruga Films Technology Center, Toyobo Co., Ltd., 10-24 Toyo-cho, Tsuruga, Fukui 914-8550, Japan., Inagaki J; Frontier Materials Technology Center, Toyobo Co., Ltd., 2-1-1 Katata, Otsu, Shiga 520-0292, Japan., Yamada R; Graduate School of Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan., Tashiro N; Graduate School of Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan., Ito K; Innovation Division, TOYOBO Co., Ltd., Osaka Umeda Twin Towers South,1-13-1 Umeda, Kita-ku, Osaka 530-0001, Japan., Sasaki M; Institute of Industrial Nanomaterials, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.; International Research Organization for Advanced Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.

Publikováno v: ACS omega [ACS Omega] 2024 Mar 04; Vol. 9 (11), pp. 13125-13133. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).

Host-produced ADAMTS4 Inhibits Early-Stage Tumor Growth

Autor: Asano, K., Edamatsu, M., Hatipoglu, O. F., Inagaki, J., Ono, M., Ohtsuki, T., Toshitaka Oohashi, Hirohata, S.

Publikováno v: Scopus-Elsevier

Several research groups demonstrated that ‘a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs (ADAMTS)’-family proteases play roles in cancer progression. However, the origins and contributions of these proteases are not k

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d3f62be9d2080964b3344c75c0e1ef9
https://pubmed.ncbi.nlm.nih.gov/29926003

Potential of a Novel Chemical Compound Targeting Matrix Metalloprotease-13 for Early Osteoarthritis: An In Vitro Study.

Autor: Inagaki J; Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan., Nakano A; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Hatipoglu OF; Department of Pharmacology, Faculty of Medicine, Kindai University, Higashi-Sayama, Osaka 577-8502, Japan., Ooka Y; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Tani Y; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Miki A; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Ikemura K; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Opoku G; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Ando R; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Kodama S; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Ohtsuki T; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Yamaji H; Heart Rhythm Center, Okayama Heart Clinic, Takeda 54-1, Okayama 703-8251, Japan., Yamamoto S; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Katsuyama E; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Watanabe S; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan., Hirohata S; Department of Medical Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Okayama 700-8558, Japan.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 28; Vol. 23 (5). Date of Electronic Publication: 2022 Feb 28.

Nintedanib for treatment of progressive interstitial lung disease after peripheral blood stem cell transplantation in a patient with recurrent acute lymphoblastic leukemia.

Autor: Kouroki M; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Inagaki J; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Fujisaki T; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Matsuishi T; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Sato T; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Kamizono J; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan., Yasui M; Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Nov; Vol. 68 (11), pp. e29211. Date of Electronic Publication: 2021 Jul 01.